Summary of Purpose
To compare the relative efficacies of two different doses of aspirin taken daily on a long-term basis in the secondary prevention of stroke.Read More →
The following dates are available for this trial. Trial information last updated on 30 April 2001.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Medical Research Council, Beecham Products, Eli Lilly, Evans Medical/Glaxo, Wasell Packaging, Aspirin Foundation
Randomized, double-blind, placebo-controlled trial of 2435 patients at 33 centers.